TB

Tomer Berkovitz

Managing Partner @ aMoon Fund

Boston, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

Israel

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Corporate Finance
Investment Banking
Capital Markets
Financial Modeling
Valuation
Mergers & Acquisitions
Finance
IPO
Investor Relations
Venture capital

Education

Lists including Tomer

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

SF
SS
ST
SJ

Pre-Seed Investors in Boston

71 people

Investments

PrognomiQ

Series Unknown

Total Funding: $100M

Omada Health

Series E

Total Funding: $270M

Sera Prognostics

Series E

Total Funding: $140M

SOPHiA GENETICS

Series F

Total Funding: $220M

Seer

Series D

Total Funding: $170M

Work Experience

aF
aMoon Fund

2018

  • Managing Partner

    2023

  • General Partner

    2018 - 2023

    aMoon is a global HealthTech & Life Sciences Investment Manager with >$1.3B AUM. Our investment platform includes three funds: early-stage (Velocity), late-stage (Growth) and public equity (Edge).

SG
SOPHiA GENETICS

2020

  • Board Member

    2020

    NASDAQ: SOPH

AI
AltruBio Inc.

2024

  • Board Member

    2024

PI
PrognomiQ Inc

2020

  • Board Member

    2020

CH
Connie Health

2023

  • Board Member

    2023

OH
Omada Health

2021

  • Board Observer

    2021

ZM
Zebra Medical Vision Ltd

2018 - 2021

  • Board Member

    2018 - 2021

    Acquired by Nanox (NASDAQ: NNOX)

S
Seer

2019 - 2020

  • Board Observer

    2019 - 2020

    NASDAQ: SEER

A
Alcobra

2014 - 2018

  • COO & CFO

    2014 - 2018

    NASDAQ-traded biopharmaceutical company, merged with Arcturus Therapeutics (NASDAQ: ARCT)

J
JPMorgan

2008 - 2014

  • Executive Director, Investment Banking

    2012 - 2014

  • Vice President, Investment Banking

    2010 - 2011

  • Associate, Investment Banking

    2008 - 2009